Sumatriptan (all routes of administration) for acute migraine attacks in adults: an overview of Cochrane reviews

  • Protocol
  • Overview

Authors

  • R Andrew Moore,

    1. University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics), Oxford, Oxfordshire, UK
    Search for more papers by this author
  • Christopher J Derry,

    1. University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics), Oxford, Oxfordshire, UK
    Search for more papers by this author
  • Sheena Derry

    1. University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics), Oxford, Oxfordshire, UK
    Search for more papers by this author

Maura Moore, Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics), University of Oxford, Pain Research Unit, Churchill Hospital, Oxford, Oxfordshire, OX3 7LJ, UK. maura.moore@pru.ox.ac.uk.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The preparation of separate reviews for each route of administration was necessitated by the very large amount of data available for the oral and subcutaneous routes in particular; a single review including all routes would have been too lengthy and complex. The objective of this overview will be to summarise evidence from the four existing reviews on the efficacy and tolerability of sumatriptan, by all four routes of administration, compared to placebo and other active interventions in the treatment of acute migraine attacks in adults.